{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:37:24Z","timestamp":1648586244206},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:00:00Z","timestamp":1128643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10067-005-0029-9","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T11:23:43Z","timestamp":1128597823000},"page":"540-541","source":"Crossref","is-referenced-by-count":9,"title":["Successful retreatment with infliximab in patients with prior severe infusion reactions"],"prefix":"10.1007","volume":"25","author":[{"given":"Imad","family":"Uthman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinane","family":"El-Sayyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fares","family":"Zaitoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,7]]},"reference":[{"issue":"2","key":"29_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.rdc.2004.02.003","volume":"30","author":"JJ Cush","year":"2004","unstructured":"Cush JJ (2004) Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 30(2):237\u2013255","journal-title":"Rheum Dis Clin North Am"},{"issue":"1 suppl 1","key":"29_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","volume":"126","author":"J-F Colombel","year":"2004","unstructured":"Colombel J-F, Loftus EV Jr, Tremaine WJ, Sandborn WJ, Egan LJ, Harmsen WS et al (2004) The safety profile of infliximab in patients with Crohn's disease: the mayo clinic experience in 500 patients. Gastroenterology 126(1 suppl 1):19\u201331","journal-title":"Gastroenterology"},{"issue":"6","key":"29_CR3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","volume":"98","author":"S Plevy","year":"2003","unstructured":"Plevy S, Cheifetz A, Smedley M, Martin S, Reiter M, Leone G et al (2003) The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 98(6):1315\u20131324","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"29_CR4","first-page":"1912","volume":"31","author":"MJ Wasserman","year":"2004","unstructured":"Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC (2004) Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol 31(10):1912\u20131917","journal-title":"J Rheumatol"},{"issue":"9317","key":"29_CR5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al (2002) Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359(9317):1541\u20131549","journal-title":"Lancet"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"29C","DOI":"10.1155\/2000\/698523","volume":"(14 suppl) C","author":"TF Schaible","year":"2000","unstructured":"Schaible TF (2000) Long term safety of infliximab. Can J Gastroenterol (14 suppl) C:29C\u201332C","journal-title":"Can J Gastroenterol"},{"issue":"4 suppl","key":"29_CR7","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0091-6749(03)01881-5","volume":"112","author":"G Marone","year":"2003","unstructured":"Marone G, Granata F, Spadaro G, Genovese A, Triggiani M, Marone G (2003) The histamine\u2013cytokine network in allergic inflammation. J Allergy Clin Immunol 112(4 suppl):S83\u2013S88","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"29_CR8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0196-0644(00)43749-2","volume":"36","author":"RY Lin","year":"2000","unstructured":"Lin RY, Curry A, Pesola GR, Knight RJ, Lee H-S, Bakalchuk L et al (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36(5):462\u2013468","journal-title":"Ann Emerg Med"},{"issue":"6","key":"29_CR9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1572-0241.2002.05784.x","volume":"97","author":"S Kugathasan","year":"2002","unstructured":"Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D et al (2002) Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol 97(6):1408\u20131414","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0029-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0029-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0029-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:42:43Z","timestamp":1559119363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0029-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0029-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,7]]}}}